Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	demethylase activity	KDM5C KDM5D ALKBH5 UTY	1.79e-04	44	128	4	GO:0032451
GeneOntologyMolecularFunction	quaternary ammonium group binding	NF1 OGDHL ALDOB RPE65	2.13e-04	46	128	4	GO:0050997
GeneOntologyMolecularFunction	proteoglycan binding	ITGA2 NF1 CEACAM21 HRG	3.19e-04	51	128	4	GO:0043394
GeneOntologyMolecularFunction	collagen binding involved in cell-matrix adhesion	ITGA11 ITGA2	4.03e-04	5	128	2	GO:0098639
GeneOntologyMolecularFunction	dioxygenase activity	KDM5C KDM5D ALKBH5 RPE65 UTY	4.22e-04	98	128	5	GO:0051213
GeneOntologyMolecularFunction	fructose binding	SLC2A5 ALDOB	6.01e-04	6	128	2	GO:0070061
GeneOntologyMolecularFunction	collagen receptor activity	ITGA11 ITGA2	6.01e-04	6	128	2	GO:0038064
GeneOntologyMolecularFunction	histone H3K4me/H3K4me2/H3K4me3 demethylase activity	KDM5C KDM5D	6.01e-04	6	128	2	GO:0034647
GeneOntologyMolecularFunction	histone H3 demethylase activity	KDM5C KDM5D UTY	7.50e-04	28	128	3	GO:0141052
GeneOntologyMolecularFunction	2-oxoglutarate-dependent dioxygenase activity	KDM5C KDM5D ALKBH5 UTY	8.06e-04	65	128	4	GO:0016706
GeneOntologyMolecularFunction	heparan sulfate proteoglycan binding	ITGA2 CEACAM21 HRG	8.32e-04	29	128	3	GO:0043395
GeneOntologyMolecularFunction	pre-mRNA 3'-splice site binding	U2AF1L4 U2AF1	8.38e-04	7	128	2	GO:0030628
GeneOntologyMolecularFunction	histone demethylase activity	KDM5C KDM5D UTY	1.01e-03	31	128	3	GO:0032452
GeneOntologyMolecularFunction	histone H3K4 demethylase activity	KDM5C KDM5D	1.11e-03	8	128	2	GO:0032453
GeneOntologyMolecularFunction	protein demethylase activity	KDM5C KDM5D UTY	1.11e-03	32	128	3	GO:0140457
GeneOntologyMolecularFunction	phosphatidylcholine binding	NF1 ALDOB RPE65	1.33e-03	34	128	3	GO:0031210
GeneOntologyMolecularFunction	extracellular matrix structural constituent	NID2 VTN LAMA1 TECTA HMCN1 MUC2	1.35e-03	188	128	6	GO:0005201
GeneOntologyMolecularFunction	cell-matrix adhesion mediator activity	ITGA11 ITGA2	1.43e-03	9	128	2	GO:0098634
GeneOntologyMolecularFunction	cell adhesion mediator activity	ITGA11 DSG2 ITGA2 PLXNB3	1.45e-03	76	128	4	GO:0098631
GeneOntologyMolecularFunction	collagen binding	NID2 ITGA11 VTN ITGA2	1.83e-03	81	128	4	GO:0005518
GeneOntologyCellularComponent	microvillus	ESPN KIF13B MYO6 PODXL LRRK2 CD302 SLC27A4	1.19e-05	123	130	7	GO:0005902
GeneOntologyCellularComponent	side of membrane	HFE ITGA11 TRAF2 FLT3 HLA-DPB1 ADAM20 LRRK2 ITGA2 TECTA CEACAM21 LPA CD274 CD302 MDGA1 ATP2A2	3.59e-04	875	130	15	GO:0098552
GeneOntologyCellularComponent	protein complex involved in cell adhesion	ITGA11 VTN LAMA1 ITGA2	4.99e-04	59	130	4	GO:0098636
GeneOntologyCellularComponent	cell surface	HFE NID2 ITGA11 FLT3 DSG2 HLA-DPB1 ADAM20 ITGA2 BMPR2 CEACAM21 LPA C1QBP CD274 HRG CD302 MDGA1 PLXNB3	5.32e-04	1111	130	17	GO:0009986
MousePheno	detached tectorial membrane	ESPN MYO6 TECTA	1.37e-05	7	104	3	MP:0003150
Domain	ig	FLT3 SEMA3A CEACAM21 HMCN1 KIR2DL5A KIR3DL1 MDGA1 KIR3DL2 IGLON5	8.35e-06	190	132	9	PF00047
Domain	Immunoglobulin	FLT3 SEMA3A CEACAM21 HMCN1 KIR2DL5A KIR3DL1 MDGA1 KIR3DL2 IGLON5	8.35e-06	190	132	9	IPR013151
Domain	IG_LIKE	HFE FLT3 MYLK TRIO HLA-DPB1 SEMA3A CEACAM21 HMCN1 CD274 KIR2DL5A KIR3DL1 MDGA1 KIR3DL2 IGLON5	1.01e-05	491	132	14	PS50835
Domain	Ig-like_dom	HFE FLT3 MYLK TRIO HLA-DPB1 SEMA3A CEACAM21 HMCN1 CD274 KIR2DL5A KIR3DL1 MDGA1 KIR3DL2 IGLON5	1.32e-05	503	132	14	IPR007110
Domain	IG	FLT3 MYLK TRIO SEMA3A CEACAM21 HMCN1 CD274 KIR2DL5A KIR3DL1 MDGA1 KIR3DL2 IGLON5	4.49e-05	421	132	12	SM00409
Domain	Ig_sub	FLT3 MYLK TRIO SEMA3A CEACAM21 HMCN1 CD274 KIR2DL5A KIR3DL1 MDGA1 KIR3DL2 IGLON5	4.49e-05	421	132	12	IPR003599
Domain	-	HFE FLT3 MYLK TRIO HLA-DPB1 SEMA3A CEACAM21 HMCN1 CD274 KIR2DL5A KIR3DL1 MDGA1 KIR3DL2 IGLON5 PLXNB3	7.05e-05	663	132	15	2.60.40.10
Domain	C8	TECTA FCGBP MUC2	7.25e-05	12	132	3	PF08742
Domain	TIL	TECTA FCGBP MUC2	7.25e-05	12	132	3	PF01826
Domain	Unchr_dom_Cys-rich	TECTA FCGBP MUC2	9.37e-05	13	132	3	IPR014853
Domain	C8	TECTA FCGBP MUC2	9.37e-05	13	132	3	SM00832
Domain	TIL_dom	TECTA FCGBP MUC2	1.19e-04	14	132	3	IPR002919
Domain	Ig-like_fold	HFE FLT3 MYLK TRIO HLA-DPB1 SEMA3A CEACAM21 HMCN1 CD274 KIR2DL5A KIR3DL1 MDGA1 KIR3DL2 IGLON5 PLXNB3	1.41e-04	706	132	15	IPR013783
Domain	TILa_dom	TECTA FCGBP	1.48e-04	3	132	2	IPR025615
Domain	G2F	NID2 HMCN1	1.48e-04	3	132	2	SM00682
Domain	TILa	TECTA FCGBP	1.48e-04	3	132	2	PF12714
Domain	VWF_type-D	TECTA FCGBP MUC2	1.81e-04	16	132	3	IPR001846
Domain	VWFD	TECTA FCGBP MUC2	1.81e-04	16	132	3	PS51233
Domain	VWD	TECTA FCGBP MUC2	1.81e-04	16	132	3	SM00216
Domain	VWD	TECTA FCGBP MUC2	1.81e-04	16	132	3	PF00094
Domain	Lys_sp_deMease-like_dom	KDM5C KDM5D	2.95e-04	4	132	2	IPR013637
Domain	G2F	NID2 HMCN1	2.95e-04	4	132	2	PF07474
Domain	NIDOGEN_G2	NID2 HMCN1	2.95e-04	4	132	2	PS50993
Domain	GFP	NID2 HMCN1	2.95e-04	4	132	2	IPR009017
Domain	PLU-1	KDM5C KDM5D	2.95e-04	4	132	2	PF08429
Domain	G2_nidogen/fibulin_G2F	NID2 HMCN1	2.95e-04	4	132	2	IPR006605
Domain	VWC_out	TECTA FCGBP MUC2	3.08e-04	19	132	3	SM00215
Domain	Hexapep	EIF2B5 GMPPA	4.89e-04	5	132	2	IPR001451
Domain	NIDO_dom	NID2 TECTA	4.89e-04	5	132	2	IPR003886
Domain	NIDO	NID2 TECTA	4.89e-04	5	132	2	SM00539
Domain	U2AF_small	U2AF1L4 U2AF1	4.89e-04	5	132	2	IPR009145
Domain	NIDO	NID2 TECTA	4.89e-04	5	132	2	PF06119
Domain	NIDO	NID2 TECTA	4.89e-04	5	132	2	PS51220
Domain	Hexapep	EIF2B5 GMPPA	4.89e-04	5	132	2	PF00132
Domain	zf-C5HC2	KDM5C KDM5D	4.89e-04	5	132	2	PF02928
Domain	Znf_C5HC2	KDM5C KDM5D	4.89e-04	5	132	2	IPR004198
Domain	JmjC	KDM5C KDM5D UTY	6.26e-04	24	132	3	PF02373
Domain	RBD-FIP	RAB11FIP1 RAB11FIP5	7.30e-04	6	132	2	PF09457
Domain	Rab-bd_FIP-RBD	RAB11FIP1 RAB11FIP5	7.30e-04	6	132	2	IPR019018
Domain	FIP_RBD	RAB11FIP1 RAB11FIP5	7.30e-04	6	132	2	PS51511
Domain	JMJC	KDM5C KDM5D UTY	1.47e-03	32	132	3	PS51184
Domain	JmjC_dom	KDM5C KDM5D UTY	1.47e-03	32	132	3	IPR003347
Domain	JmjC	KDM5C KDM5D UTY	1.61e-03	33	132	3	SM00558
Domain	JmjN	KDM5C KDM5D	2.15e-03	10	132	2	SM00545
Domain	JmjN	KDM5C KDM5D	2.15e-03	10	132	2	PF02375
Domain	JMJN	KDM5C KDM5D	2.15e-03	10	132	2	PS51183
Domain	JmjN	KDM5C KDM5D	2.15e-03	10	132	2	IPR003349
Domain	Ig_I-set	MYLK TRIO CEACAM21 HMCN1 MDGA1 IGLON5	2.33e-03	190	132	6	IPR013098
Domain	I-set	MYLK TRIO CEACAM21 HMCN1 MDGA1 IGLON5	2.33e-03	190	132	6	PF07679
Domain	VWC	TECTA FCGBP MUC2	2.43e-03	38	132	3	SM00214
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	HFE ITGA11 DSG2 PODXL LAMA1 TMED7 CACHD1 ITGA2 ATP9A MBOAT2 TXNDC11 ITPR2 SEMA3A BMPR2 NF1 PRDX3 SCAPER C1QBP ATP2A2	1.69e-07	1201	133	19	35696571
Pubmed	X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.	KDM5C KDM5D UTY	2.18e-07	4	133	3	32732223
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DL5B KIR2DL5A KIR3DL1 KIR3DL2	3.59e-07	16	133	4	16403292
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DL5B KIR2DL5A KIR3DL1 KIR3DL2	4.68e-07	17	133	4	20878400
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DL5B KIR2DL5A KIR3DL1 KIR3DL2	4.68e-07	17	133	4	20650299
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DL5B KIR2DL5A KIR3DL1 KIR3DL2	4.68e-07	17	133	4	19218127
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DL5B KIR2DL5A KIR3DL1 KIR3DL2	4.68e-07	17	133	4	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DL5B KIR2DL5A KIR3DL1 KIR3DL2	4.68e-07	17	133	4	19761533
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DL5B KIR2DL5A KIR3DL1 KIR3DL2	6.00e-07	18	133	4	20200544
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	KIR2DL5B KIR2DL5A KIR3DL1 KIR3DL2	9.44e-07	20	133	4	20193031
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	KIR2DL5B KIR2DL5A KIR3DL1 KIR3DL2	9.44e-07	20	133	4	20426625
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	KIR2DL5B KIR2DL5A KIR3DL1 KIR3DL2	1.42e-06	22	133	4	20492596
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	NID2 VTN LAMA1 HMCN1 ADAMTS20	4.82e-06	64	133	5	22261194
Pubmed	Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.	KIR2DL5B KIR2DL5A KIR3DL1 KIR3DL2	9.76e-06	35	133	4	19683555
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].	KIR2DL5A KIR3DL1 KIR3DL2	1.17e-05	12	133	3	17490516
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DL5A KIR3DL1 KIR3DL2	1.17e-05	12	133	3	20137308
Pubmed	Targeting RIPK1 in AML cells carrying FLT3-ITD.	FLT3 RIPK1	1.45e-05	2	133	2	30828789
Pubmed	Mouse brain proteomics establishes MDGA1 and CACHD1 as in vivo substrates of the Alzheimer protease BACE1.	CACHD1 MDGA1	1.45e-05	2	133	2	31908000
Pubmed	Targeting tumor cell-to-macrophage communication by blocking Vtn-C1qbp interaction inhibits tumor progression via enhancing macrophage phagocytosis.	VTN C1QBP	1.45e-05	2	133	2	38773982
Pubmed	Inverse correlation between fatty acid transport protein 4 and vision in Leber congenital amaurosis associated with RPE65 mutation.	RPE65 SLC27A4	1.45e-05	2	133	2	33257550
Pubmed	Integrin α2 promotes immune escape in non-small-cell lung cancer by enhancing PD-L1 expression in exosomes to inhibit CD8 + T-cell activity.	ITGA2 CD274	1.45e-05	2	133	2	37804164
Pubmed	Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B.	KIR2DL5B KIR2DL5A	1.45e-05	2	133	2	12185535
Pubmed	Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene.	KIR2DL5B KIR2DL5A	1.45e-05	2	133	2	11086080
Pubmed	Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx.	KDM5C KDM5D	1.45e-05	2	133	2	10441747
Pubmed	Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.	KIR3DL1 KIR3DL2	1.45e-05	2	133	2	11207248
Pubmed	Cell micropatterning reveals the modulatory effect of cell shape on proliferation through intracellular calcium transients.	ITPR2 ATP2A2	1.45e-05	2	133	2	28962833
Pubmed	Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus.	KDM5C KDM5D	1.45e-05	2	133	2	16416087
Pubmed	Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila.	LRRK2 PRDX3	1.45e-05	2	133	2	24459295
Pubmed	Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death.	LRRK2 PRDX3	1.45e-05	2	133	2	21850687
Pubmed	Mutations of histone demethylase genes encoded by X and Y chromosomes, Kdm5c and Kdm5d, lead to noncompaction cardiomyopathy in mice.	KDM5C KDM5D	1.45e-05	2	133	2	32081420
Pubmed	NDRG2 attenuates ischemia-induced astrocyte necroptosis via the repression of RIPK1.	RIPK1 NDRG2	1.45e-05	2	133	2	32945444
Pubmed	The IgGFc-binding protein FCGBP is secreted with all GDPH sequences cleaved but maintained by interfragment disulfide bonds.	FCGBP MUC2	1.45e-05	2	133	2	34126068
Pubmed	Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4.	KIR2DL5B KIR2DL5A	1.45e-05	2	133	2	17215859
Pubmed	The zinc finger domains in U2AF26 and U2AF35 have diverse functionalities including a role in controlling translation.	U2AF1L4 U2AF1	1.45e-05	2	133	2	32116123
Pubmed	Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death.	TRAF2 RIPK1	1.45e-05	2	133	2	15199146
Pubmed	KIR3DL1 and KIR3DL2 gene copy number variation in axial spondyloarthritis.	KIR3DL1 KIR3DL2	1.45e-05	2	133	2	25940819
Pubmed	A mouse Y chromosome gene encoded by a region essential for spermatogenesis and expression of male-specific minor histocompatibility antigens.	KDM5C KDM5D	1.45e-05	2	133	2	7524912
Pubmed	Impacts of deletion and ichthyosis prematurity syndrome-associated mutations in fatty acid transport protein 4 on the function of RPE65.	RPE65 SLC27A4	1.45e-05	2	133	2	31595490
Pubmed	Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer.	KIR3DL1 KIR3DL2	1.45e-05	2	133	2	8777725
Pubmed	M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma.	ALKBH5 CD274	1.45e-05	2	133	2	34301762
Pubmed	Diversity of the p70 killer cell inhibitory receptor (KIR3DL) family members in a single individual.	KIR3DL1 KIR3DL2	1.45e-05	2	133	2	10774747
Pubmed	Ablation of Fatty Acid Transport Protein-4 Enhances Cone Survival, M-cone Vision, and Synthesis of Cone-Tropic 9-cis-Retinal in rd12 Mouse Model of Leber Congenital Amaurosis.	RPE65 SLC27A4	1.45e-05	2	133	2	38811164
Pubmed	Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension.	BMPR2 ATP2A2	1.45e-05	2	133	2	34502015
Pubmed	Integrins α2β1 and α11β1 regulate the survival of mesenchymal stem cells on collagen I.	ITGA11 ITGA2	1.45e-05	2	133	2	21796158
Pubmed	Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein.	FCGBP MUC2	1.45e-05	2	133	2	19432394
Pubmed	Differential isoform expression and interaction with the P32 regulatory protein controls the subcellular localization of the splicing factor U2AF26.	U2AF1L4 C1QBP	1.45e-05	2	133	2	18460468
Pubmed	Reduced granulation tissue and wound strength in the absence of α11β1 integrin.	ITGA11 ITGA2	1.45e-05	2	133	2	25634355
Pubmed	Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven.	KDM5C KDM5D	1.45e-05	2	133	2	9060413
Pubmed	The binding protein for globular heads of complement C1q, gC1qR. Functional expression and characterization as a novel vitronectin binding factor.	VTN C1QBP	1.45e-05	2	133	2	8900153
Pubmed	Increased Expression of Y-Encoded Demethylases During Differentiation of Human Male Neural Stem Cells.	KDM5D UTY	1.45e-05	2	133	2	33040644
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DL5B KIR2DL5A KIR3DL1	1.52e-05	13	133	3	19120281
Pubmed	Sex differences in structure and expression of the sex chromosome genes CHD1Z and CHD1W in zebra finches.	KDM5C KDM5D UTY	1.52e-05	13	133	3	14660691
Pubmed	Dynamic patterns of histone H3 lysine 4 methyltransferases and demethylases during mouse preimplantation development.	KDM5C ASH1L KDM5D	1.52e-05	13	133	3	24619213
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DL5A KIR3DL1 KIR3DL2	1.93e-05	14	133	3	19875891
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DL5A KIR3DL1 KIR3DL2	1.93e-05	14	133	3	19489269
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DL5A KIR3DL1 KIR3DL2	1.93e-05	14	133	3	15896204
Pubmed	Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.	KIR2DL5A KIR3DL1 KIR3DL2	1.93e-05	14	133	3	18945962
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DL5A KIR3DL1 KIR3DL2	2.41e-05	15	133	3	20082646
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DL5A KIR3DL1 KIR3DL2	2.41e-05	15	133	3	20356536
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DL5A KIR3DL1 KIR3DL2	2.41e-05	15	133	3	19926642
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DL5A KIR3DL1 KIR3DL2	2.41e-05	15	133	3	20643584
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DL5A KIR3DL1 KIR3DL2	2.41e-05	15	133	3	17498266
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DL5A KIR3DL1 KIR3DL2	2.41e-05	15	133	3	19326408
Pubmed	The integral function of the endocytic recycling compartment is regulated by RFFL-mediated ubiquitylation of Rab11 effectors.	KIF13B MYO6 RAB11FIP1 RAB11FIP5	2.94e-05	46	133	4	30659120
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DL5A KIR3DL1 KIR3DL2	2.95e-05	16	133	3	19897003
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DL5A KIR3DL1 KIR3DL2	2.95e-05	16	133	3	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DL5A KIR3DL1 KIR3DL2	2.95e-05	16	133	3	20670355
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DL5A KIR3DL1 KIR3DL2	2.95e-05	16	133	3	18668235
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DL5A KIR3DL1 KIR3DL2	2.95e-05	16	133	3	19309280
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DL5A KIR3DL1 KIR3DL2	2.95e-05	16	133	3	19527230
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DL5A KIR3DL1 KIR3DL2	2.95e-05	16	133	3	20652381
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DL5A KIR3DL1 KIR3DL2	2.95e-05	16	133	3	19279038
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DL5A KIR3DL1 KIR3DL2	2.95e-05	16	133	3	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DL5A KIR3DL1 KIR3DL2	2.95e-05	16	133	3	18643961
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DL5A KIR3DL1 KIR3DL2	2.95e-05	16	133	3	20331834
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DL5A KIR3DL1 KIR3DL2	2.95e-05	16	133	3	20210919
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TRAF2 TRIO MYO6 HIPK1 ASH1L DEF8 CACHD1 CLIC6 TRIM59 XAB2 TXNDC11 U2AF1 MIB1 ATP2A2 PLXNB3 BRWD1	3.40e-05	1285	133	16	35914814
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DL5A KIR3DL1 KIR3DL2	3.57e-05	17	133	3	19968064
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DL5A KIR3DL1 KIR3DL2	3.57e-05	17	133	3	19032228
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DL5A KIR3DL1 KIR3DL2	3.57e-05	17	133	3	20173792
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DL5A KIR3DL1 KIR3DL2	3.57e-05	17	133	3	20483367
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DL5A KIR3DL1 KIR3DL2	4.28e-05	18	133	3	19630074
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DL5A KIR3DL1 KIR3DL2	4.28e-05	18	133	3	19046302
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DL5A KIR3DL1 KIR3DL2	4.28e-05	18	133	3	20580654
Pubmed	Sex differences in sex chromosome gene expression in mouse brain.	KDM5C KDM5D UTY	4.28e-05	18	133	3	12023983
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DL5A KIR3DL1 KIR3DL2	4.28e-05	18	133	3	20519398
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DL5A KIR3DL1 KIR3DL2	4.28e-05	18	133	3	19846535
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	KIR2DL5A KIR3DL1 KIR3DL2	4.28e-05	18	133	3	20210918
Pubmed	Population genetic implications from sequence variation in four Y chromosome genes.	KDM5D UTY	4.34e-05	3	133	2	10861003
Pubmed	Characterization of the murine gene of gC1qBP, a novel cell protein that binds the globular heads of C1q, vitronectin, high molecular weight kininogen and factor XII.	NF1 C1QBP	4.34e-05	3	133	2	9524273
Pubmed	A novel caspase-2 complex containing TRAF2 and RIP1.	TRAF2 CASP2	4.34e-05	3	133	2	15590671
Pubmed	Haptoglobin modifies the hemochromatosis phenotype in mice.	HFE HP	4.34e-05	3	133	2	15613548
Pubmed	Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation.	TRAF2 RIPK1	4.34e-05	3	133	2	14701813
Pubmed	Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype.	KIR3DL1 KIR3DL2	4.34e-05	3	133	2	11859120
Pubmed	Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients.	ZBTB17 NDRG2	4.34e-05	3	133	2	38842567
Pubmed	Histidine-rich glycoprotein blocks collagen-binding integrins and adhesion of endothelial cells through low-affinity interaction with α2 integrin.	ITGA2 HRG	4.34e-05	3	133	2	26051322
Pubmed	CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP.	RIPK1 CASP2	4.34e-05	3	133	2	9044836
Pubmed	Characterization of U2AF(6), a splicing factor related to U2AF(35).	U2AF1L4 U2AF1	4.34e-05	3	133	2	11739736
Pubmed	Attenuation of TNFSF10/TRAIL-induced apoptosis by an autophagic survival pathway involving TRAF2- and RIPK1/RIP1-mediated MAPK8/JNK activation.	TRAF2 RIPK1	4.34e-05	3	133	2	23051914
Pubmed	Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1/3 ubiquitination.	TRAF2 RIPK1	4.34e-05	3	133	2	29352166
Cytoband	Yq11	KDM5D UTY	5.39e-04	12	133	2	Yq11
Cytoband	Ensembl 112 genes in cytogenetic band chr3q27	MCCC1 EIF2B5 C3orf70 HRG	5.44e-04	128	133	4	chr3q27
Cytoband	9p22.3	TTC39B FREM1	6.36e-04	13	133	2	9p22.3
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DL5B KIR2DL5A KIR3DL1 KIR3DL2	1.67e-06	18	90	4	620
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM5C KDM5D UTY	2.24e-04	24	90	3	485
GeneFamily	AT-rich interaction domain containing	KDM5C KDM5D	2.47e-03	15	90	2	418
GeneFamily	StAR related lipid transfer domain containing	ACOT12 STARD9	2.47e-03	15	90	2	759
GeneFamily	Immunoglobulin like domain containing	FLT3 SEMA3A CEACAM21 MDGA1 IGLON5	2.78e-03	193	90	5	594
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CFHR5 CSMD3 HP	2.87e-03	57	90	3	1179
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	FLT3 ITGA2 CD274 KIR2DL5A CD302 KIR3DL1 KIR3DL2	3.51e-03	394	90	7	471
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA11 ITGA2	3.56e-03	18	90	2	1160
Coexpression	GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP	TTC39B ZBTB17 PGGHG TRIO AKNAD1 DEF8 SYCP1 BRWD1	8.20e-06	200	132	8	M6988
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO6 ASH1L KDM5D CYFIP2 SCAPER ZFR ATP2A2 UTY	1.18e-07	195	131	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO6 ASH1L KDM5D CYFIP2 SCAPER ZFR ATP2A2 UTY	1.18e-07	195	131	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	3'-Adult-Distal_Rectal-Epithelial-goblet\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIF13B EPS8L1 ITPR2 ANKRD36B FCGBP FAM177B MUC2	5.29e-07	162	131	7	075f73ff10e1a7f5695e014e47acc4db513e9cfb
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZSCAN25 KDM5D RAB11FIP1 SEMA3A BMPR2 HMCN1 MIB1	7.91e-07	172	131	7	f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCell	facs-Heart-LV-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZSCAN25 KDM5D RAB11FIP1 SEMA3A BMPR2 HMCN1 MIB1	7.91e-07	172	131	7	6ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 LAMA1 CSMD3 FREM1 HMCN1 ADAMTS20 DNAH11	1.24e-06	184	131	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 LAMA1 CSMD3 FREM1 HMCN1 ADAMTS20 DNAH11	1.24e-06	184	131	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 LAMA1 CSMD3 FREM1 HMCN1 ADAMTS20 DNAH11	1.24e-06	184	131	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	15-Distal-RBC\|Distal / Age, Tissue, Lineage and Cell class	ESPN VTN HP PAH SYCP1 HRG ALDOB	1.43e-06	188	131	7	c68ccb1c5c21d13ddac09b16e7d466f0530bbda5
ToppCell	15-Distal-RBC-RBC\|Distal / Age, Tissue, Lineage and Cell class	ESPN VTN HP PAH SYCP1 HRG ALDOB	1.43e-06	188	131	7	2534684e4932c1255c24a26ca2277ac7af0a118b
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSG2 MYO6 CLIC6 RAB11FIP1 FCGBP HP LIPM	1.77e-06	194	131	7	0ef63abcfd057079a9a6f8b27404ff521d44845d
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF13B VTN RIPK1 ASH1L NDRG2 BMPR2 CD302	1.83e-06	195	131	7	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	AT2_cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	DSG2 MYO6 CACHD1 CLIC6 ITGA2 ATP9A HMCN1	1.96e-06	197	131	7	5e0d222872a25bb9e9069d3dffda2844bb69874a
ToppCell	TCGA-Breast-Metastatic-Breast_Carcinoma\|TCGA-Breast / Sample_Type by Project: Shred V9	VTN CFHR5 LPA HRG TRIM40 ALDOB	5.30e-06	149	131	6	c7dc495141cd921b6b6f291a68851b7b807d0d0a
ToppCell	TCGA-Breast-Metastatic-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma\|TCGA-Breast / Sample_Type by Project: Shred V9	VTN CFHR5 LPA HRG TRIM40 ALDOB	5.30e-06	149	131	6	2e9b898f3df22f8e872f2c278eff454c39e55b3b
ToppCell	TCGA-Breast-Metastatic\|TCGA-Breast / Sample_Type by Project: Shred V9	VTN CFHR5 LPA HRG TRIM40 ALDOB	5.30e-06	149	131	6	144ac2c458209ce510674bc2f83eb4c8e4d3c953
ToppCell	droplet-Liver-nan-3m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 HP PAH HRG ALDOB	7.16e-06	157	131	6	b72c6a1ed17bfc32d9dec193d934ea82e80b6bd5
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA1 TECTA FREM1 SEMA3A HMCN1 SYCP1	7.97e-06	160	131	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA1 TECTA FREM1 SEMA3A HMCN1 SYCP1	7.97e-06	160	131	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 HP PAH HRG ALDOB	8.87e-06	163	131	6	61b4e38d7bbbb031100670928e6fd4f7ea23814f
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 HP PAH HRG ALDOB	8.87e-06	163	131	6	0b4d234bdd57d5e991f68942333ca89f70ea28df
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 HP PAH HRG ALDOB	8.87e-06	163	131	6	cc728796e52d0e6cc1198e0732370c62380e951d
ToppCell	368C-Myeloid-Dendritic-cDC_activated\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	NID2 FLT3 VTN DSG2 MBOAT2 CD274	9.18e-06	164	131	6	67c636a2cc32e56c6186dc7e779cc19af04639d2
ToppCell	facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSG2 PODXL RAB11FIP1 SEMA3A HMCN1 RPE65	1.05e-05	168	131	6	06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46
ToppCell	facs-Heart-RA-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSG2 PODXL RAB11FIP1 SEMA3A HMCN1 RPE65	1.05e-05	168	131	6	1002f058a340763e3d8de0bd1f0547a903526ec6
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESPN NDRG2 FREM1 MDGA1 RPE65 IGLON5	1.20e-05	172	131	6	e15ab284df6dd241d4481f98864b18c39d757b8c
ToppCell	Endothelial-B-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	NID2 PODXL AKNAD1 FREM1 GGT5 SEMA3A	1.20e-05	172	131	6	8a527dff06d841a86c7eb04a1dd9630787294da4
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KIF13B FRMPD4 CSMD3 MBOAT2 FREM1 DNAH11	1.46e-05	178	131	6	51d2188406f04329311b2efd1108fc36617a860e
ToppCell	BAL-Mild-cDC_4\|Mild / Compartment, Disease Groups and Clusters	LRRK2 CYFIP2 GGT5 ANKRD36B STARD9 L3MBTL3	1.51e-05	179	131	6	68511e87b12b8253de7771e5ccfc5869248b8450
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KIF13B FRMPD4 CSMD3 MBOAT2 FREM1 DNAH11	1.56e-05	180	131	6	cfc8bfbfd3617aabbb49f9730c29b673ca157e74
ToppCell	COVID-19-kidney-CD-IC-B\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KIF13B FRMPD4 CSMD3 MBOAT2 FREM1 OGDHL	1.66e-05	182	131	6	ee6a8c356bbbdae55e4ea858337e079491f9f4aa
ToppCell	Adult-Epithelial-basal_cell\|Adult / Lineage, Cell type, age group and donor	FRMPD4 CACHD1 CLIC6 ITGA2 HMCN1 LPA	1.71e-05	183	131	6	00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSG2 CACHD1 CLIC6 MAMDC4 SEMA3A HMCN1	1.71e-05	183	131	6	b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VTN PGGHG CSMD3 HP HRG ALDOB	1.76e-05	184	131	6	7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba
ToppCell	3'_v3-bone_marrow-Myeloid_Dendritic-DC1\|bone_marrow / Manually curated celltypes from each tissue	FLT3 MYLK DSG2 HLA-DPB1 PPM1J NDRG2	1.76e-05	184	131	6	ee295f6fa898da53883e1358b17f2c2dd177e9a7
ToppCell	10x5'-GI_small-bowel-Myeloid_Dendritic-DC1\|GI_small-bowel / Manually curated celltypes from each tissue	FLT3 HLA-DPB1 LRRK2 PPM1J NDRG2 GGT5	1.82e-05	185	131	6	23ffba9216729b5bdb30b35742ba2627bb1200bf
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CALCR DSG2 MYO6 ATP9A FREM1 ITPR2	1.88e-05	186	131	6	a6ef5d5944af5689b5f27bef89cd05645eedbe50
ToppCell	10x5'-Liver-Myeloid_Dendritic-DC1\|Liver / Manually curated celltypes from each tissue	FLT3 MYLK HLA-DPB1 LRRK2 PPM1J NDRG2	1.88e-05	186	131	6	e823529ffd06352c6bdec102f221fdf27f7c7369
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VTN CFHR5 HP PAH HRG ALDOB	1.93e-05	187	131	6	edb0ab0154542b1c0b3a2c216c4a60f0f06290b3
ToppCell	390C-Myeloid-Dendritic-cDC_activated\|390C / Donor, Lineage, Cell class and subclass (all cells)	FLT3 VTN HLA-DPB1 RAB11FIP1 MBOAT2 CD274	1.93e-05	187	131	6	60c2576f31a60f819deb9ec500d1f714b469df4e
ToppCell	COVID-19-kidney-CD-IC-B\|kidney / Disease (COVID-19 only), tissue and cell type	KIF13B FRMPD4 CSMD3 MBOAT2 FREM1 DNAH11	1.93e-05	187	131	6	ce05b89860573fe0356102e2998d1ef6d1968034
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CALCR LAMA1 CACHD1 ITGA2 FREM1 HMCN1	1.99e-05	188	131	6	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CALCR DSG2 MYO6 ATP9A FREM1 ITPR2	1.99e-05	188	131	6	e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCell	3'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIF13B EPS8L1 MBOAT2 ANKRD36B FCGBP MUC2	2.05e-05	189	131	6	7dad62bd50c197838058e89abd0ee387de3e83cd
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSG2 RAB11FIP1 ITPR2 SEMA3A BMPR2 HMCN1	2.05e-05	189	131	6	8e583ec4df0f5b79ce5211cc99ecd8616d180bde
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VTN CFHR5 HP PAH HRG ALDOB	2.05e-05	189	131	6	7899af78b273d9c7f029d52f7e0cf6df4da41f5e
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VTN CFHR5 HP PAH HRG ALDOB	2.11e-05	190	131	6	a34293601aefe5fb5c400c14091294b9ddaa195b
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELAPOR2 MBOAT2 SLC2A5 CYFIP2 OGDHL ATP2A2	2.24e-05	192	131	6	5b7093d5af5ae7b0e6d3a464cc56272440ecedad
ToppCell	(2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)\|World / Stress and Cell class	NID2 MYLK NDRG2 GGT5 HP CD302	2.31e-05	193	131	6	f31398dad5321a7bcb27e208bd73630e9756e897
ToppCell	VE-mDC1-\|VE / Condition, Cell_class and T cell subcluster	FLT3 MYLK LRRK2 PPM1J NDRG2 MBOAT2	2.31e-05	193	131	6	5df6033bc0e4f96a20d526486a8e89c990e21831
ToppCell	MS-mDC1\|MS / Condition, Cell_class and T cell subcluster	FLT3 MYLK HLA-DPB1 LRRK2 PPM1J NDRG2	2.31e-05	193	131	6	4d08ebf555954d6a873a4b4c4d661dc5dd8a5bcb
ToppCell	MS-mDC1-\|MS / Condition, Cell_class and T cell subcluster	FLT3 MYLK HLA-DPB1 LRRK2 PPM1J NDRG2	2.31e-05	193	131	6	ce873f20b93e3b57c9385ee10d4becebe32ada06
ToppCell	VE-mDC1\|VE / Condition, Cell_class and T cell subcluster	FLT3 MYLK LRRK2 PPM1J NDRG2 MBOAT2	2.31e-05	193	131	6	12b2708db9db8b88365b8ebeb4908f28c50081bb
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO6 CLIC6 RAB11FIP1 ITPR2 FCGBP HP	2.31e-05	193	131	6	1526f51b589a7dc7a28f35f0e788dc38d338d2bc
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSG2 MYO6 CLIC6 RAB11FIP1 FCGBP HP	2.31e-05	193	131	6	22ebc3f586eb0aabc5785e468c88d7416c624ff4
ToppCell	BAL-Mild-Myeloid-cDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLT3 HLA-DPB1 NDRG2 MBOAT2 GGT5 IGLON5	2.45e-05	195	131	6	6ba23e19801305e071b0e4aaf1ee6f53f3b027d3
ToppCell	BAL-Mild-Myeloid-cDC-cDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLT3 HLA-DPB1 NDRG2 MBOAT2 GGT5 IGLON5	2.45e-05	195	131	6	66e5fd9f3208a06d617c5e994822bf57dceae7e2
ToppCell	BAL-Mild-Myeloid-cDC-cDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLT3 HLA-DPB1 NDRG2 MBOAT2 GGT5 IGLON5	2.45e-05	195	131	6	7209babdff96c93cd52cfe5d5cfd7e3c0274d8dd
ToppCell	Control-Myeloid-cDC1\|Control / Disease, Lineage and Cell Type	FLT3 MYLK HLA-DPB1 PPM1J NDRG2 C1QBP	2.45e-05	195	131	6	35b2fe0588877d30cbd5d3ae259fcfd959907429
ToppCell	BAL-Mild-Myeloid-cDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLT3 HLA-DPB1 NDRG2 MBOAT2 GGT5 IGLON5	2.45e-05	195	131	6	9e5cf33b5dd455efa464a63d7116786c0786aefd
ToppCell	Mild_COVID-19-Myeloid-cDC\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	FLT3 HLA-DPB1 NDRG2 MBOAT2 GGT5 IGLON5	2.45e-05	195	131	6	24149bb6933135b1a0a5c7f505914942b3782c3a
ToppCell	tumor_Lymph_Node_/_Brain\|World / Location, Cell class and cell subclass	ESPN DSG2 EPS8L1 CLIC6 RAB11FIP1 SEMA3A	2.52e-05	196	131	6	b39f938cbef54f08c53035738b97c76e7295733a
ToppCell	normal-na-Myeloid-conventional_dendritic_cell-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	FLT3 HLA-DPB1 RAB11FIP1 NDRG2 PRDX3 CD302	2.59e-05	197	131	6	17c6d2a7baef6393c3e2d3e65cc924df22049eb0
ToppCell	normal-na-Myeloid-conventional_dendritic_cell\|normal / PBMC cell types (v2) per disease, treatment status, and sex	FLT3 HLA-DPB1 RAB11FIP1 NDRG2 PRDX3 CD302	2.59e-05	197	131	6	9a0bcb055b1a5fd5439e4a0bf1742f009331df47
ToppCell	(2)_5-FU-(3)_LEPR+_perivascular_cells\|World / Stress and Cell class	NID2 MYLK NDRG2 GGT5 HP CD302	2.59e-05	197	131	6	434ae0231972acba12d06279908cf407e70511ac
ToppCell	Monocytes-cDCs\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	FLT3 DSG2 HLA-DPB1 RAB11FIP1 NDRG2 MBOAT2	2.59e-05	197	131	6	15cb9fe1c3bab80bd24728fd9ac7ba385912ac33
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DSG2 MYO6 PODXL EPS8L1 ITGA2 MBOAT2	2.67e-05	198	131	6	270cecff42b87b7e03f09dd9f99547b287b4598c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DSG2 MYO6 PODXL EPS8L1 ITGA2 MBOAT2	2.67e-05	198	131	6	8b3f4effaaccf8777cde854d5d8a765962f7312b
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	ELAPOR2 VTN DSG2 PODXL SEMA3A HP	2.74e-05	199	131	6	6cfefd81e8a1a883fb4279ac4ab0b298ed2a0817
ToppCell	myeloid-pro-cDC\|World / Lineage and Cell class	FLT3 RAB11FIP1 PPM1J NDRG2 PRDX3 CD302	2.74e-05	199	131	6	05652da8747d608b515324f90b3a70155a9c9898
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DSG2 MYO6 PODXL EPS8L1 ITGA2 RAB11FIP1	2.82e-05	200	131	6	f386a86b127433cbac306950443355bd723080ff
ToppCell	Sigmoid-(5)_Dendritic_cell-(51)_cDC1\|Sigmoid / shred on region, Cell_type, and subtype	FLT3 MYLK HLA-DPB1 PPM1J NDRG2 MBOAT2	2.82e-05	200	131	6	4ce0a2238c90622e41fd86ac4b7d82adf4af2c3b
ToppCell	Sigmoid-Dendritic_cell-cDC1\|Sigmoid / Region, Cell class and subclass	FLT3 MYLK HLA-DPB1 PPM1J NDRG2 MBOAT2	2.82e-05	200	131	6	3523ec986e8c9e176e08836c974b1de8b56d8b16
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DSG2 MYO6 PODXL EPS8L1 ITGA2 RAB11FIP1	2.82e-05	200	131	6	b75154417c215b8853186bff46d624ebd387ac4f
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	NID2 MYLK LAMA1 FREM1 LPA CD302	2.82e-05	200	131	6	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Sepsis-Int-URO-Myeloid-cDC1\|Int-URO / Disease, condition lineage and cell class	FLT3 MYLK HLA-DPB1 PPM1J NDRG2 C1QBP	2.82e-05	200	131	6	77479f733cc4ce62a07ab33d5dc2d41c911c74fc
ToppCell	Control-Control-Myeloid-cDC1\|Control / Disease, condition lineage and cell class	FLT3 MYLK HLA-DPB1 PPM1J NDRG2 C1QBP	2.82e-05	200	131	6	86db36c9f9316bfa4d8fa26c5a8239fd2d7d34c2
ToppCell	PBMC-Severe-cDC_2\|Severe / Compartment, Disease Groups and Clusters	AMT ATP9A HMCN1 MDGA1	5.12e-05	69	131	4	0fab02d29408415d3aa1f42a55a2e37b458c4030
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRMPD4 ATP9A CSMD3 MBOAT2 DNAH11	7.20e-05	146	131	5	ec1f793409d1a81c0f9323eb3c82ffe01dae0e44
ToppCell	droplet-Liver-hepatocytes-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 PAH HRG ALDOB	7.20e-05	146	131	5	d9df42f8e44018b149a84f07c540cdba74d6374a
ToppCell	droplet-Liver-hepatocytes\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 PAH HRG ALDOB	7.20e-05	146	131	5	a9fa64617c7fb7a66de77360c5642c1da91e465c
ToppCell	droplet-Liver-hepatocytes-3m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 PAH HRG ALDOB	7.20e-05	146	131	5	e03658ead410d003e2b18fe94da086a38560b8e7
ToppCell	droplet-Liver-hepatocytes-3m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 PAH HRG ALDOB	7.20e-05	146	131	5	9d7122cc640500c7cd93230df06e331c31625bd5
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMT ASH1L HMCN1 HP SLC27A4	7.68e-05	148	131	5	b4632029ebd14969bda59a1bd1454eadb8efe563
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMT ASH1L HMCN1 HP SLC27A4	7.68e-05	148	131	5	ba277c898678dd36f8dc1d681301c71901b89055
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_dendritic_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FLT3 HLA-DPB1 LRRK2 PPM1J OGDHL	7.92e-05	149	131	5	71d72a6e7b128ee96161e08f6a0d77be925e73a1
ToppCell	droplet-Liver-hepatocytes-3m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 HP HRG ALDOB	8.18e-05	150	131	5	ee2da4f684add821f2653d5db8eef46cd95c0fda
ToppCell	10x5'v1-week_12-13-Myeloid_DC-DC-DC2\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FLT3 HLA-DPB1 PPM1J NDRG2 C1QBP	9.84e-05	156	131	5	03f3c5ffb27758fe63797143fcc938f9e8a4e10d
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 HP HRG ALDOB	1.04e-04	158	131	5	9f58428f70d1427b20122c5c1cc7bf521d0f4832
ToppCell	facs-Liver\|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN HP PAH HRG CD302	1.04e-04	158	131	5	ea7db6bd9742153ceb6e444892a6d1df9c7fcc96
ToppCell	3'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITPR2 ANKRD36B FCGBP FAM177B MUC2	1.08e-04	159	131	5	6ec5489d55667e53bd9c021ada7de458bfef43a3
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC39B MYO6 ITGA2 PPM1J MAMDC4	1.08e-04	159	131	5	d2de9391b00b6c47f5fe28a1bad6da2097107ee0
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC39B MYO6 ITGA2 PPM1J MAMDC4	1.08e-04	159	131	5	da6b7f8039adc19839d6c090a0b3d68fb6445a79
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 HP PAH HRG	1.11e-04	160	131	5	8de1fc75241d9bf2b355afa0e9ef39fea1977177
ToppCell	ICU-SEP-Myeloid-cDC1\|ICU-SEP / Disease, Lineage and Cell Type	ITGA11 FLT3 MYLK PPM1J NDRG2	1.14e-04	161	131	5	9fb73909fc2ec99f96ca2eed1a053bce89de7d16
ToppCell	droplet-Pancreas-Exocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN LAMA1 CLIC6 HP PAH	1.17e-04	162	131	5	922ecea81063095b8dd9ac9f9792bf551edbb848
ToppCell	droplet-Liver-Hepatocytes\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 HP PAH HRG	1.21e-04	163	131	5	a794540f2d8984f963c08f05175e4bc916fcc224
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 HP PAH HRG	1.21e-04	163	131	5	03d9fa615d9d02ef98e20f28a10aaa6894dd4960
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 HP PAH HRG	1.21e-04	163	131	5	1c4de36cf8cdaabb981cda5c7ce7e5ae7b4280e3
ToppCell	droplet-Liver-Hepatocytes-18m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NDRG2 HP PAH HRG	1.21e-04	163	131	5	7e82c1b7849eca895732df2da74ac6430bd9ba7a
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A	TRIO CASP2 ITPR2 ADRA1D BMPR2 NF1 PRDX3 ZFR UTY	1.63e-06	189	132	9	5084_DN
Drug	fluphenazine dihydrochloride; Up 200; 10uM; SKMEL5; HG-U133A	HFE AMT ADAM20 NDRG2 BMPR2 ARNT ARR3 PRDX3 HRG	1.94e-06	193	132	9	494_UP
Drug	Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	HFE AMT KDM5C NDRG2 NF1 PRDX3 ANGEL2 SCAPER UTY	2.20e-06	196	132	9	4120_DN
Drug	Mevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; MCF7; HT_HG-U133A	HFE TRAF2 AMT TRIO NDRG2 ZNF16 NF1 SCAPER UTY	2.30e-06	197	132	9	3459_UP
Drug	Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A	HFE ZBTB17 CASP2 EPS8L1 ITGA2 ITPR2 NF1 UTY ZNF614	2.39e-06	198	132	9	7327_UP
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; HL60; HT_HG-U133A	HFE PGGHG CASP2 ITPR2 ADRA1D BMPR2 ARNT NF1 UTY	2.39e-06	198	132	9	2458_DN
Drug	Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; MCF7; HT_HG-U133A	HFE EPS8L1 MBOAT2 FBXO38 ARNT NF1 SCAPER RAB11FIP5 ZNF614	2.50e-06	199	132	9	7429_UP
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; HL60; HT_HG-U133A	HFE TRAF2 DEF8 XAB2 ARNT NF1 PRDX3 SCAPER	1.87e-05	195	132	8	2432_DN
Drug	quercetin dihydrate; Up 200; 1uM; MCF7; HG-U133A	TRAF2 VRK3 MYO6 BMPR2 ARNT HRG UTY BRWD1	1.94e-05	196	132	8	283_UP
Drug	Pyrithyldione [77-04-3]; Down 200; 24uM; MCF7; HT_HG-U133A	HFE ZBTB17 ASH1L NDRG2 XAB2 ADRA1D ARNT SCAPER	1.94e-05	196	132	8	3482_DN
Drug	Ioxaglic acid [59017-64-0]; Up 200; 3.2uM; MCF7; HT_HG-U133A	HFE ZBTB17 CASP2 EPS8L1 ARNT NF1 CD302 UTY	1.94e-05	196	132	8	7470_UP
Drug	Xamoterol hemifumarate [73210-73-8]; Down 200; 5uM; HL60; HT_HG-U133A	ZBTB17 SLC2A5 FBXO38 ZNF16 ARNT ARR3 NF1 MUC2	2.01e-05	197	132	8	3064_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	HFE KDM5C ASH1L ITGA2 XAB2 ARNT NF1 RAB11FIP5	2.08e-05	198	132	8	1669_DN
Drug	Isopyrin hydrochloride [18342-39-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A	HFE MYLK TRIO CASP2 SLC2A5 NF1 SCAPER SYCP1	2.08e-05	198	132	8	7233_UP
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A	HFE AMT ZBTB17 KDM5C ASH1L EPS8L1 NF1 ZNF614	2.16e-05	199	132	8	3543_DN
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A	HFE TRAF2 ZBTB17 TRIO ASH1L EPS8L1 USP46 ZFR	2.24e-05	200	132	8	7002_DN
Drug	T 113242	ZBTB17 ITGA2	9.97e-05	3	132	2	ctd:C436947
Drug	C2(+)	KIR3DL1 KIR3DL2	9.97e-05	3	132	2	CID006857645
Drug	Halcinonide [3093-35-4]; Up 200; 8.8uM; HL60; HT_HG-U133A	FLT3 MBOAT2 ITPR2 TG ARR3 NF1 ANGEL2	1.01e-04	184	132	7	2185_UP
Drug	angiogenesis inhibitor	NID2 SEMA3A LPA MIB1 SYCP1 HRG	1.03e-04	128	132	6	CID002812173
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	TRIO CASP2 ITPR2 BMPR2 ARNT NF1 ZFR	1.20e-04	189	132	7	3788_DN
Drug	Azlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; MCF7; HT_HG-U133A	HFE TRAF2 AMT CASP2 EPS8L1 ITPR2 ARR3	1.24e-04	190	132	7	3468_UP
Drug	Chrysene-1,4-quinone [100900-16-1]; Up 200; 15.4uM; HL60; HG-U133A	HFE NDRG2 XAB2 ARNT NF1 GMPPA ZNF614	1.28e-04	191	132	7	1773_UP
Drug	Econazole nitrate [24169-02-6]; Up 200; 9uM; MCF7; HT_HG-U133A	HFE MYLK CALCR ASH1L SLC2A5 ARNT SCAPER	1.28e-04	191	132	7	6008_UP
Drug	Norethynodrel [68-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A	HFE NDRG2 TMEM177 FBXO38 ADRA1D NF1 ANGEL2	1.32e-04	192	132	7	1696_UP
Drug	Orlistat; Up 200; 10uM; PC3; HT_HG-U133A	HFE TRIO EPS8L1 ARNT NF1 ADAMTS20 HRG	1.32e-04	192	132	7	6388_UP
Drug	Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A	MYO6 HIPK1 CASP2 ITPR2 SCAPER ZFR ZNF614	1.41e-04	194	132	7	4272_DN
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	HFE ASH1L CASP2 EPS8L1 NDRG2 NF1 BRWD1	1.41e-04	194	132	7	6021_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A	HFE AMT MYLK KDM5C CASP2 EPS8L1 NF1	1.41e-04	194	132	7	4758_DN
Drug	(R)-(+)-Atenolol [56715-13-0]; Up 200; 15uM; MCF7; HT_HG-U133A	HFE ZBTB17 PGGHG CASP2 ITPR2 ZNF16 ATP2A2	1.45e-04	195	132	7	2855_UP
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; HL60; HT_HG-U133A	OCEL1 KDM5C CASP2 NF1 ZFR GMPPA UTY	1.45e-04	195	132	7	2359_DN
Drug	Amoxapine [14028-44-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A	TRAF2 TRIO CASP2 CYFIP2 ARNT ANGEL2 ZNF614	1.45e-04	195	132	7	4996_DN
Drug	NSC635470	ITGA2 KDM5D HP	1.46e-04	18	132	3	CID000003664
Drug	Allantoin [97-59-6]; Down 200; 25.2uM; PC3; HT_HG-U133A	TRIO CASP2 FBXO38 ARNT NF1 UTY BRWD1	1.50e-04	196	132	7	5052_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A	HFE CASP2 CYFIP2 ZNF16 ADRA1D NF1 ANGEL2	1.50e-04	196	132	7	4749_DN
Drug	Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A	TRAF2 ASH1L EPS8L1 FBXO38 BMPR2 ARNT NF1	1.50e-04	196	132	7	2628_DN
Drug	estradiol, USP; Down 200; 0.01uM; PC3; HT_HG-U133A	TRIO EPS8L1 ARNT NF1 ANGEL2 SCAPER ADAMTS20	1.50e-04	196	132	7	4465_DN
Drug	tetraethylenepentamine pentahydrochloride; Down 200; 100uM; HL60; HG-U133A	HFE OCEL1 EPS8L1 NDRG2 TG NF1 CD302	1.50e-04	196	132	7	412_DN
Drug	Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A	HFE CASP2 TAAR5 SLC2A5 CYFIP2 BMPR2 SCAPER	1.50e-04	196	132	7	1487_UP
Drug	(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; HL60; HT_HG-U133A	HFE OCEL1 TRAF2 FLT3 NDRG2 ARNT UTY	1.50e-04	196	132	7	2969_UP
Drug	Ethamsylate [2624-44-4]; Up 200; 15.2uM; MCF7; HT_HG-U133A	HFE EPS8L1 NDRG2 ARNT NF1 ANGEL2 ZNF614	1.50e-04	196	132	7	7335_UP
Drug	Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A	HFE KIF13B KDM5C ZNF16 ARNT ARR3 NF1	1.55e-04	197	132	7	6507_DN
Drug	Loracarbef [121961-22-6]; Down 200; 10.8uM; HL60; HT_HG-U133A	OCEL1 NDRG2 SLC2A5 ITPR2 BMPR2 ARNT UTY	1.55e-04	197	132	7	2970_DN
Drug	Pyrazinamide [ 98-96-4]; Up 200; 32.4uM; MCF7; HT_HG-U133A	HFE PGGHG TAAR5 NDRG2 ARNT NF1 ADAMTS20	1.55e-04	197	132	7	2839_UP
Drug	estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A	CASP2 EPS8L1 SLC2A5 ARR3 NF1 CEACAM21 ZNF614	1.55e-04	197	132	7	5960_UP
Drug	Vincamine [1617-90-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A	HFE CALCR CASP2 ARR3 NF1 UTY ZNF614	1.55e-04	197	132	7	2327_UP
Drug	Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; HL60; HT_HG-U133A	HFE ADAM20 SLC2A5 ITPR2 ARR3 RAB11FIP5 ALDOB	1.55e-04	197	132	7	2362_UP
Drug	Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; HL60; HT_HG-U133A	HFE EPS8L1 MBOAT2 ITPR2 NF1 HRG ALDOB	1.55e-04	197	132	7	2556_UP
Drug	Gleevec; Down 200; 10uM; PC3; HG-U133A	MYO6 CASP2 EPS8L1 KDM5D NDRG2 ARNT CEACAM21	1.55e-04	197	132	7	483_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	HFE KIF13B OCEL1 TRAF2 CASP2 ITGA2 SCAPER	1.55e-04	197	132	7	1641_UP
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; HL60; HT_HG-U133A	ZBTB17 CASP2 EPS8L1 CYFIP2 ADRA1D BMPR2 ATP2A2	1.55e-04	197	132	7	2170_DN
Drug	Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A	HFE AMT ZBTB17 KDM5C CASP2 EPS8L1 NF1	1.55e-04	197	132	7	3299_DN
Drug	clozapine; Down 200; 10uM; MCF7; HT_HG-U133A	HFE RIPK1 KDM5C EPS8L1 ZNF16 NF1 UTY	1.55e-04	197	132	7	5589_DN
Drug	Diprophylline [479-18-5]; Up 200; 15.8uM; HL60; HT_HG-U133A	HFE AMT CASP2 USP46 SLC2A5 ITPR2 ARNT	1.55e-04	197	132	7	1853_UP
Drug	Colchicine [64-86-8]; Down 200; 10uM; MCF7; HT_HG-U133A	HFE ASH1L ZNF16 NF1 SCAPER CD302 UTY	1.55e-04	197	132	7	5675_DN
Drug	Acenocoumarol [152-72-7]; Up 200; 11.4uM; MCF7; HT_HG-U133A	HFE PGGHG NDRG2 TG NF1 ADAMTS20 ALDOB	1.59e-04	198	132	7	7232_UP
Drug	Amoxapine [14028-44-5]; Up 200; 12.8uM; HL60; HG-U133A	HFE AMT RIPK1 EPS8L1 GMEB2 CYFIP2 NF1	1.59e-04	198	132	7	2013_UP
Drug	Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Up 200; 11.8uM; HL60; HT_HG-U133A	DEF8 NDRG2 SLC2A5 ARNT ARR3 CEACAM21 ANGEL2	1.59e-04	198	132	7	2158_UP
Drug	raloxifene hydrochloride; Up 200; 0.1uM; ssMCF7; HG-U133A	TRIO DSG2 ITPR2 TMEM177 CEACAM21 ANGEL2 UTY	1.59e-04	198	132	7	376_UP
Drug	Pizotifen malate [5189-11-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A	KIF13B CALCR ADAM20 CASP2 NDRG2 SCAPER ALDOB	1.59e-04	198	132	7	5491_UP
Drug	Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A	HFE FLT3 ZBTB17 CALCR ITGA2 CEACAM21 ALDOB	1.59e-04	198	132	7	3894_UP
Drug	Sulfachloropyridazine [80-32-0]; Down 200; 14uM; HL60; HT_HG-U133A	OCEL1 TRAF2 ZBTB17 ARNT RAB11FIP5 UTY BRWD1	1.59e-04	198	132	7	2191_DN
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; HL60; HT_HG-U133A	RAB11FIP1 SLC2A5 FBXO38 ARNT SCAPER GMPPA BRWD1	1.64e-04	199	132	7	2357_DN
Drug	rapamycin; Up 200; 0.1uM; MCF7; HG-U133A	TRIO DSG2 FBXO38 ZNF16 CEACAM21 ANKRD28 ZFR	1.64e-04	199	132	7	326_UP
Drug	Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; HL60; HG-U133A	AMT ASH1L DEF8 EPS8L1 ITPR2 ARNT ZNF614	1.64e-04	199	132	7	1739_UP
Drug	Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; HL60; HT_HG-U133A	TRAF2 PGGHG ASH1L ADRA1D BMPR2 SCAPER UTY	1.64e-04	199	132	7	2449_DN
Drug	Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; PC3; HT_HG-U133A	HFE CALCR ITPR2 ADRA1D NF1 ALDOB ZNF614	1.64e-04	199	132	7	4067_UP
Drug	Iopromide [73334-07-3]; Down 200; 5uM; MCF7; HT_HG-U133A	KIF13B USP46 ITPR2 ADRA1D ARNT NF1 SCAPER	1.64e-04	199	132	7	3481_DN
Drug	Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	ASH1L ITGA2 CYFIP2 TMEM177 ZNF16 ARNT UTY	1.64e-04	199	132	7	2830_DN
Drug	iodine atom	ITGA2 TG KIR3DL1	1.72e-04	19	132	3	CID005360629
Drug	dihydrosanguinarine	ITGA2 KIR3DL2	1.99e-04	4	132	2	CID000124069
Drug	1a-n	VTN ITGA2	1.99e-04	4	132	2	CID000009584
Drug	dichlorosilylene	ITGA2 HP	1.99e-04	4	132	2	CID000061330
Disease	thrombosis (is_implicated_in)	VTN ITGA2 HRG	3.57e-05	15	129	3	DOID:0060903 (is_implicated_in)
Disease	apolipoprotein B measurement	HFE KIF13B TTC39B VTN AKNAD1 DPYSL5 NF1 LPA L3MBTL3 ATG4D DNAH11 BRWD1	3.59e-05	663	129	12	EFO_0004615
Disease	syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology)	KDM5C KDM5D	1.13e-04	4	129	2	DOID:0060809 (implicated_via_orthology)
Disease	response to bronchodilator, response to corticosteroid	CSMD3 ZNF614	1.88e-04	5	129	2	GO_0031960, GO_0097366
Disease	juvenile myelomonocytic leukemia (implicated_via_orthology)	FLT3 NF1	1.88e-04	5	129	2	DOID:0050458 (implicated_via_orthology)
Disease	alcohol use disorder (implicated_via_orthology)	KDM5C EPS8L1 CLIC6 KDM5D ADRA1D UTY	2.24e-04	195	129	6	DOID:1574 (implicated_via_orthology)
Disease	hypothyroidism	HFE FLT3 HLA-DPB1 HIPK1 TG CD274 CD302	2.61e-04	284	129	7	EFO_0004705
Disease	iron deficiency anemia (is_implicated_in)	HFE ITGA2	2.81e-04	6	129	2	DOID:11758 (is_implicated_in)
Disease	protocadherin-10 measurement	VTN HRG	2.81e-04	6	129	2	EFO_0801978
Disease	muellerian-inhibiting factor measurement	VTN CD302	2.81e-04	6	129	2	EFO_0020584
Disease	solute carrier family 35 member G2 measurement	VTN HRG	2.81e-04	6	129	2	EFO_0802080
Disease	pulmonary hypertension (is_implicated_in)	BMPR2 HP ATP2A2	3.04e-04	30	129	3	DOID:6432 (is_implicated_in)
Disease	Profound Mental Retardation	KDM5C LAMA1 CASP2 NF1 SCAPER	3.72e-04	139	129	5	C0020796
Disease	Mental Retardation, Psychosocial	KDM5C LAMA1 CASP2 NF1 SCAPER	3.72e-04	139	129	5	C0025363
Disease	Mental deficiency	KDM5C LAMA1 CASP2 NF1 SCAPER	3.72e-04	139	129	5	C0917816
Disease	sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) measurement	VTN HRG	3.93e-04	7	129	2	EFO_0803304
Disease	sensorineural hearing loss (is_implicated_in)	MYO6 ITGA2 TECTA	4.05e-04	33	129	3	DOID:10003 (is_implicated_in)
Disease	E3 ubiquitin-protein ligase RNF13 measurement	VTN HRG	5.22e-04	8	129	2	EFO_0801556
Disease	CD27 antigen measurement	VTN HRG	5.22e-04	8	129	2	EFO_0008078
Disease	Hepatitis B, Chronic	HLA-DPB1 HP	5.22e-04	8	129	2	C0524909
Disease	Dermatitis, Irritant	HLA-DPB1 TRIM40	6.69e-04	9	129	2	C0162823
Disease	hip circumference	TTC39B NID2 ELAPOR2 CALCR NF1 HMCN1 L3MBTL3	7.37e-04	338	129	7	EFO_0005093
Disease	Intellectual Disability	FRMPD4 TRIO KDM5C LAMA1 ASH1L CASP2 NF1 SCAPER	8.05e-04	447	129	8	C3714756
Disease	theophylline measurement	LRRK2 ITGA2	8.34e-04	10	129	2	EFO_0021180
Disease	WNT1-inducible-signaling pathway protein 1 measurement	VTN TG	8.34e-04	10	129	2	EFO_0008321
Disease	myocardial infarction (is_implicated_in)	HFE ITGA2 HP LPA	9.52e-04	99	129	4	DOID:5844 (is_implicated_in)
Disease	gastrin-releasing peptide measurement	VTN HRG	1.02e-03	11	129	2	EFO_0022000
Disease	interleukin-22 receptor subunit alpha-2 measurement	FLT3 VTN	1.02e-03	11	129	2	EFO_0020500
Disease	persulfide dioxygenase ETHE1, mitochondrial measurement	VTN HRG	1.22e-03	12	129	2	EFO_0008258
Disease	Hereditary hemochromatosis	HFE HP	1.22e-03	12	129	2	C0392514
Disease	Hemochromatosis	HFE HP	1.22e-03	12	129	2	C0018995
Disease	Crohn Disease	VTN LRRK2 MUC2	1.38e-03	50	129	3	C0010346
Disease	transmembrane protein 87B measurement	VTN HRG	1.43e-03	13	129	2	EFO_0802158
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	ESPN MYO6 TECTA	1.46e-03	51	129	3	cv:CN043650
Disease	complement factor H-related protein 1 measurement	VTN FRMPD4 CFHR5	1.91e-03	56	129	3	EFO_0600054
Disease	semaphorin-3A measurement	VTN HRG	1.92e-03	15	129	2	EFO_0008278
Disease	quinate measurement	LRRK2 ITGA2	1.92e-03	15	129	2	EFO_0021167
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	HFE LPA DNAH11 BRWD1	1.94e-03	120	129	4	EFO_0004611, EFO_0004639
Disease	syndromic intellectual disability (implicated_via_orthology)	KDM5C KDM5D	2.19e-03	16	129	2	DOID:0050888 (implicated_via_orthology)
Disease	Post-Traumatic Osteoporosis	CALCR U2AF1 PRDX3	2.44e-03	61	129	3	C0751406
Disease	Osteoporosis, Senile	CALCR U2AF1 PRDX3	2.44e-03	61	129	3	C0029459
Disease	Osteoporosis, Age-Related	CALCR U2AF1 PRDX3	2.44e-03	61	129	3	C0001787
Disease	Sarcomatoid Renal Cell Carcinoma	KDM5C LRRK2 CASP2 CSMD3	2.45e-03	128	129	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	KDM5C LRRK2 CASP2 CSMD3	2.45e-03	128	129	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	KDM5C LRRK2 CASP2 CSMD3	2.45e-03	128	129	4	C1266044
Disease	Papillary Renal Cell Carcinoma	KDM5C LRRK2 CASP2 CSMD3	2.45e-03	128	129	4	C1306837
Disease	Renal Cell Carcinoma	KDM5C LRRK2 CASP2 CSMD3	2.45e-03	128	129	4	C0007134
Disease	Osteoporosis	CALCR U2AF1 PRDX3	2.68e-03	63	129	3	C0029456
Disease	Allergic Reaction	MYLK HP CD274	2.68e-03	63	129	3	C1527304
Disease	Malignant neoplasm of breast	NID2 CFHR5 TECTA MAMDC4 SLC2A5 SEMA3A BMPR2 NF1 HP C1QBP HRG L3MBTL3	2.68e-03	1074	129	12	C0006142
Disease	Hypersensitivity	MYLK HP CD274	2.80e-03	64	129	3	C0020517
Disease	low density lipoprotein cholesterol measurement, physical activity	HFE LPA DNAH11	3.06e-03	66	129	3	EFO_0003940, EFO_0004611
Disease	squamous cell carcinoma (is_marker_for)	RIPK1 RPE65	3.09e-03	19	129	2	DOID:1749 (is_marker_for)
Disease	coronary artery disease (is_marker_for)	VTN HP LPA	3.19e-03	67	129	3	DOID:3393 (is_marker_for)
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	KDM5C LRRK2 CASP2 CSMD3	4.12e-03	148	129	4	C0279702
Disease	C-peptide measurement	LRRK2 TRIM40	4.14e-03	22	129	2	EFO_0005187
Disease	apolipoprotein A 1 measurement	HFE TTC39B FLT3 VTN TRIM59 BMPR2 LPA ANKRD28 TRIM40 ALDOB	4.16e-03	848	129	10	EFO_0004614
Disease	non-high density lipoprotein cholesterol measurement	HFE KIF13B VTN BMPR2 HP LPA L3MBTL3 DNAH11 BRWD1	4.19e-03	713	129	9	EFO_0005689

Protein segments in the cluster

Peptide	Gene	Start	Entry
DDVEYLAGQHCQQPA	MAMDC4	1126	Q6UXC1
VDHRCVATVGYQPQE	ARNT	376	P27540
VNSDVEHYLCEQCDP	ASH1L	2616	Q9NR48
TEQYLEVELCPHGQH	C4orf33	71	Q8N1A6
LHDVVEVYDGPTQQS	CSMD3	1811	Q7Z407
ALVLDCHYPEDEVGQ	C1QBP	181	Q07021
AAAEAGDIPIYICHQ	CALCR	431	P30988
TSHQCPDDVYVQDGI	ADAM20	481	O43506
PDDVYVQDGISCNVN	ADAM20	486	O43506
VIPDGDHDLEHCQYV	ALDOB	191	P05062
VINDYQPGGCIVSHV	ALKBH5	191	Q6P6C2
QEDAGEYQCEVSNPV	CEACAM21	206	Q3KPI0
DCVLVVGEENEYPVQ	CD302	216	Q8IX05
TPLHVACYNGQDVVV	ANKRD28	241	O15084
CEVHQEPVTYTAIDP	CACHD1	996	Q5VU97
TPQQGDVYTCQVEHT	HLA-DPB1	191	P04440
YVPFQAECECVGHVE	DNAH11	1686	Q96DT5
EDDQLYHITCPILND	ACOT12	431	Q8WYK0
HGTNIEECSKNEYQP	ANKRD36B	141	Q8N2N9
LCLQEVQEDHYGAEI	ANGEL2	216	Q5VTE6
GINAIGAHYVESCDE	C3orf70	191	A6NLC5
CPADQEIEHAYSDVA	CLIC6	686	Q96NY7
YHGEPISVNVSINNC	ARR3	206	P36575
IHEGQTVQVDDHYCG	ADAMTS20	936	P59510
TVQVDDHYCGDQLKP	ADAMTS20	941	P59510
PGINVKCVQYDEHVI	GMEB2	111	Q9UKD1
HELTCQAEGYPKAEV	CD274	151	Q9NZQ7
LCVNGSHIYNEEPQG	RAB11FIP5	336	Q9BXF6
DQYGEFLELQHEVGC	OCEL1	171	Q9H607
THDDCIPEVKIAYVN	ITPR2	1411	Q14571
QDPQEVTYAQLDHCV	KIR3DL2	391	P43630
QDPQEVTYAQLDHCV	KIR2DL5A	291	Q8N109
EGVDPEHQSVYCVLT	L3MBTL3	271	Q96JM7
EPVQTICHDAEYVNV	DSG2	501	Q14126
SCHVDAVPQEKVTYQ	MDGA1	356	Q8NFP4
EYTVDVEGHGCTFIQ	OVOS1	1081	Q6IE37
QTVENGYHDNPTLEV	PODXL	501	O00592
HGVNQDDVGVYTCLV	MYLK	221	Q15746
CEVFDPQEHENINGV	HRG	241	P04196
QDQCIRHYEGSTVPE	HP	306	P00738
CTTLPVEYNIDEHFQ	MBOAT2	251	Q6ZWT7
EIIQHQGYPCEEYEV	LIPM	51	Q5VYY2
GEGDYQLVQHEILCS	HIPK1	171	Q86Z02
EVTQYLVQECGADPH	ESPN	186	B1AK53
ADVDEIQNGDHYPCL	KDM5D	1021	Q9BY66
AYLPVHVNEEEGVVA	DCAF4L2	316	Q8NA75
PGCHIGDNVVLDQTY	EIF2B5	381	Q13144
VPNEKCHLEAGVQEY	FAM177B	131	A6PVY3
CHLEAGVQEYGTIQQ	FAM177B	136	A6PVY3
QDPQEVTYAQLDHCV	KIR2DL5B	291	Q8NHK3
QDPEEVTYAQLDHCV	KIR3DL1	391	P43629
EHCPEGERTIYSAQE	PLXNB3	656	Q9ULL4
HVNADDPEAVIYVCS	OGDHL	461	Q9ULD0
HCVEDGTYLATEVNP	MUC2	4861	Q02817
YVHNGCPILDEDTVK	FREM1	91	Q5H8C1
AYCLVGSEVLDNHPE	LRRK2	1746	Q5S007
CHNVTPVYESNGVTD	ATP9A	466	O75110
SYNDVVVGAPLEDNH	ITGA11	556	Q9UKX5
EVCPEDIYGVQEVHV	PGGHG	356	Q32M88
EEQRYTCQVEHPGLD	HFE	276	Q30201
TQCLHQQLEVIPGYE	CYFIP2	221	Q96F07
SCPEHIIYIQEPSDV	ITGA2	736	P17301
YFQIHTPCDEEGKTQ	ELAPOR2	351	A8MWY0
FYHLPTGCQEIAEVE	IPMK	366	Q8NFU5
YCGFHEDNIPQLEDV	PAH	216	P00439
HIERVQLQDGGEYTC	HMCN1	946	Q96RW7
CGIDEDHDIVVQYPS	MIB1	286	Q86YT6
DDQYVPQCDDLGHFI	NID2	1036	Q14112
IFIHYCDVNGEPVED	FBXO38	1171	Q6PIJ6
QNVDGRVSECPHTYQ	FLT3	956	P36888
NYGCIVENPQTHEVL	GMPPA	151	Q96IJ6
PVNCHQYDGLVELAT	ATP2A2	401	P16615
GEYECVTHNGVNSAP	IGLON5	191	A6NGN9
LPHEYQGISQDQLIC	HYLS1	156	Q96M11
VGCEITCPENSHYEV	FCGBP	4346	Q9Y6R7
IEEPLLHDICYAENT	FRMPD4	731	Q14CM0
SHIGDPQECHYEECV	BMPR2	86	Q13873
ILHVNSKGCVEYEPN	GGT5	521	P36269
EELCELAPQTYLNGH	AKNAD1	546	Q5T1N1
EAPTEQSPGVQDCYH	LPA	1156	P08519
EQSPTVQDCYHGDGQ	LPA	1266	P08519
GSVHCEVPSEQYACE	BRWD1	1981	Q9NSI6
PYQHGVSVEVNCRNE	CFHR5	286	Q9BXR6
PVVEGYHGEDQSDQC	MCCC1	176	Q96RQ3
SHQAEYELNICPETG	DEF8	256	Q6ZN54
AVNYHCNEVDPGAEV	DAZL	211	Q92904
CLYGNDIDEHTTPVE	AMT	271	P48728
VQHQDCSPLSGDYVI	METTL13	386	Q8N6R0
YPVNHLVTFCLGEDD	EPS8L1	36	Q8TE68
QAEPGQYCKEEVHIQ	C9orf57	101	Q5W0N0
IVCVGYFTVNHPDNQ	SCAPER	1271	Q9BY12
LGYDVHVLCDQTAQE	CASP2	236	P42575
DCTHEADVYIENGII	DPYSL5	21	Q9BPU6
LEQNENGEYCPVEVI	KIF13B	996	Q9NQT8
IQGAEEHPAAFCYQV	TAAR5	6	O14804
NDEPAHYCSICEVEV	UTY	1271	O14607
NVCINGNHVYLEQPE	RAB11FIP1	316	Q6WKZ4
PHIENDGTVYNIGNC	RPE65	181	Q16518
CVTDPAYEDVNNCHE	XAB2	86	Q9HCS7
SEEVLGTGYICPNHQ	TRIM40	61	Q6P9F5
EVPVVENHLCNAEYH	TPSD1	186	Q9BZJ3
VGDQAPHEDAVVECN	NDRG2	261	Q9UN36
DQIYLSAGVPEEHVQ	SLC2A5	301	P22732
VVAADVEHCECPQGY	LAMA1	701	P25391
CVVDAALEYVPGAHQ	LAMA1	2701	P25391
DLTQYEHCPDDVLVL	PPM1J	411	Q5JR12
VKAFQYVETHGEVCP	PRDX3	216	P30048
ALHTEEENYNVVAPG	SCFD2	316	Q8WU76
CTYIEIGHHPEDNIF	SEMA3A	141	Q14563
PHCEQAESQVEPSYS	STARD9	1301	Q9P2P6
TVYKGPNCIEHNEAL	RIPK1	46	Q13546
VPHEVAEGATCQAYE	ADRA1D	546	P25100
DPHYCQPTVDVSQAD	ATG4D	356	Q86TL0
PYGNNSHDIIDAEVT	TECTA	1791	O75443
PQNCAACVHEGIYEE	TRAF2	66	Q12933
ECYEQLGQLHPELEQ	TTC30B	66	Q8N4P2
PLQAELCYNHVVESE	TTC39B	601	Q5VTQ0
SCIQEHYLPQVIDGT	TCEANC	276	Q8N8B7
HIPQVAEFYGATECN	SLC27A4	376	Q6P1M0
VLEQVGNSDCHYQEG	SYCP1	76	Q15431
HVTPAQIDCFGEYVE	ZSCAN25	246	Q6NSZ9
LEFQVITGGHYDVDC	TMED7	61	Q9Y3B3
CGVDEVSVHNLLPNY	NF1	721	P21359
YCGNSLPVEEHVGSQ	VRK3	21	Q8IV63
VCDNLGDHLVGNVYV	U2AF1	101	Q01081
VCDNLGDHLVGNVYV	U2AF1L4	101	Q8WU68
EITEVALEYNNCHGD	TXNDC11	396	Q6PKC3
YDLVAVVVHCGSGPN	USP46	296	P62068
VQEEDPNTHILYACD	ZBTB17	706	Q13105
ALQSDVQPVGHDYVE	ZFR	556	Q96KR1
ECYEQLGQLHPELEQ	TTC30A	66	Q86WT1
SDTELEAICPHYQQP	ZNF16	51	P17020
IYHENICIQENPGSG	ZNF614	221	Q8N883
LDYFQDPVSIECGHN	TRIM4	16	Q9C037
QEVLQDIGVPSGHCY	TMEM177	66	Q53S58
TCPGVTYDQESHQVI	TG	1776	P01266
EYQFQHQPSQEECEG	VTN	281	P04004
YQQEDHPDIVTCPEH	TRIM59	86	Q8IWR1
QTGECDPEEIYQAAH	TRIO	636	O75962
VDEIQNGDHYPCLDD	KDM5C	1036	P41229
LGVNEVHYVDNQDCI	MYO6	501	Q9UM54